Old Web
English
Sign In
Acemap
>
authorDetail
>
Eva Maria Ruiz de Castilla
Eva Maria Ruiz de Castilla
Latin Americans
Economic growth
Biosimilar
Traceability
Pace
5
Papers
44
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A civil society view of rare disease public policy in six Latin American countries.
2020
Orphanet Journal of Rare Diseases
Mo Mayrides
Eva Maria Ruiz de Castilla
Silvina Szelepski
Show All
Source
Cite
Save
Citations (7)
Los tiempos COVID-19 y post-COVID-19: debemos asegurarnos de que la voz del paciente siempre sea escuchada
2020
Eva Maria Ruiz de Castilla
Show All
Source
Cite
Save
Citations (0)
Manifiesto por la seguridad de los pacientes usuarios de medicamentos biotecnológicos en América Latina y el Caribe
2019
Eva Maria Ruiz de Castilla
Show All
Source
Cite
Save
Citations (0)
HTA Implementation in Latin American Countries: Comparison of Current and Preferred Status
2017
Value in health regional issues
Diego Rosselli
Camila Quirland-Lazo
Marcell Csanádi
Eva Maria Ruiz de Castilla
Nelly Cisneros González
Julio Valdes
Cesar Abicalaffe
William Garzón
Giovanny Leon
Zoltán Kaló
Show All
Source
Cite
Save
Citations (12)
Recommendations for the regulation of biosimilars and their implementation in Latin America
2014
Generics and Biosimilars Initiative journal
Valderílio Feijó Azevedo
Eduardo Mysler
Alexis Aceituno Álvarez
Juana Hughes
Francisco Javier Flores Murrieta
Eva Maria Ruiz de Castilla
Show All
Source
Cite
Save
Citations (25)
1